Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma
Year: 2004
Type: article
Source: Clinical Lymphoma
Institutions: Duke University, Duke Medical Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2039024712
